GSK Will Answer FDA “Complete Response” Letter For Cervarix In Second Quarter
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory committee review of the human papilloma virus vaccine expected, CEO Garnier says during year-end earnings call.